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Allosteric Mechanism of Hemoglobin: Concerted Mechanisms or Graded
Mechanisms
Takashi Yonetani.
Univ. Pennsylvania, Philadelphia, PA, USA.
Allosteric parameters (KT, KR, and Ln) of hemoglobin (Hb) are normally de-
termined by thermodynamic analyses of oxygen-binding isotherma according
to the Monod-Wyman-Changeux two-state concerted model [1]. KT and KR
are independent of ligation states [1,2], whereas Ln is a function of the number
of ligands bound. On the other hands, in structure-linked graded models such as
the Koshland-Nemethy-Filmer sequential model [3], the Perutz steroechemical
model [4], and the Eaton et al. tertiary two-state (TTS) model [5], the oxygen-
affinity (Kn (n ¼ 1, 2, 3, & 4)) of Hb is linked to certain ligation-induced struc-
tural changes (tertiary and/or quaternary) such as changes in salt bridges and T/
R-quaternary structures. Then, the oxygen-binding processes become circular
reversible kinetic processes, as schematically shown in the figure, rather than
the truely reversible kinetic process as expected thermodynamically. Supported
by NIH HL14508.
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Conformatinal Dynamics Of Cytochrome c Encapsulated In AOT Reverse
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Scalable interior volume of the reverse micelle provides a convenient way to
investigate the impact of aqueous solvation and confinement on the structure,
stability and dynamics of proteins and peptides. Here we report transient ab-
sorption study of CO rebinding to cytochrome c encapsulated in AOT reverse
micelles. Encapsulation of cytochrome c is associated with the destabilization
of the protein structure and concomitant dissociation of Met-80 from the heme
iron as evident from the disappearance of the absorption band at 695 nm. Re-
duction of cytochrome c and subsequent exposure to CO result in the formation
of CO bound protein with a Soret band located at 415 nm. Upon photodissoci-
ation, the ligand rebinding occurs as a two-step process with the first step hav-
ing the lifetime of 7 ms and slower process with the lifetime of roughly 50 ms.
No significant impact of the reverse micelle size (w ¼ 10, 20 and 80) on the
kinetics of CO rebinding to cytochrome c was observed. On the other hand,
CO rebinding to the model compound, microperoxidase-11, is multi-phasic
with 6 ms and 50 ms kinetics on the microsecond timescale and an additional
kinetics on the millisecond timescale. These data show that the encapsulation
of protein within the negatively charged reverse micelles results in the heterog-
enous population and/or distribution of protein within the reverse micelle.
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Substrate Stereoselectivity of Human Indoleamine 2,3-Dioxygenase
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Indoleamine 2,3-dioxygenase (IDO) and Tryptophan 2,3-dioxygenase (TDO)
are two heme-containing enzymes that catalyze the oxidative cleavage of tryp-
tophan (Trp) to N-formyl-kynurenine, the initial and rate-limiting step of the
kynurenine pathway. Although IDO and TDO catalyze the same reaction,
they exhibit distinct structural and functional features. TDO plays an important
role in regulating homeostatic serum Trp concentrations, whereas IDO is in-
volved in a wide spectrum of immune related pathophysiologies. It has been
shown that immune cells express IDO to suppress pathogen growth by deplet-
ing the local Trp concentration and by producing cytotoxic metabolites.
Ironically, IDO produced in the placenta and by cancer cells has also been im-
plicated in inhibiting the proliferation of immune cells by similar mechanisms.
To study the substrate-protein interaction in human IDO (hIDO), as compared
to human TDO (hTDO), we have constructed and studied three mutants of
hIDO, including S167H and F226Y (in which the two critical amino acids in
the active site were mutated to mimic TDO), as well as trIDO (in which the
N-terminal domain absent in TDO was truncated). The structural and enzy-
matic properties of each mutant were systematically examined with optical ab-
sorption and resonance Raman spectroscopies. The data were evaluated against
the wild type hIDO and hTDO. It was concluded that: (1) the mutation of F226
to Tyr changes the substrate stereoselectivity to be ‘‘TDO-like’’; (2) the muta-
tion of S167 to His causes the inactivation of IDO; and (3) the N-terminal
domain of IDO is critical for Trp binding and activity. These studies will bediscussed in the context of the dioxygen chemistry carried out by these two im-
portant heme-containing enzymes.
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The Unique Dioxygen Activation Mechanism of Human Indoleamine 2,3-
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Human indoleamine 2,3-dioxygenase (hIDO) is an intracellular heme-containing
enzyme, which catalyzes the initial and rate-determining step of L-tryptophan (L-
Trp) metabolism via the kynurenine pathway in nonhepatic tissues. We have em-
ployed stopped-flow methods to study the L-Trp and oxygen binding kinetics of
hIDO and the associated oxygen chemistry at pH 7.4 and 20 oC. We found that
the binding rate constants of L-Trp to ferric and ferrous hIDO are 5.5*10(3) and
1.2*10(5) M-1s-1, respectively. In contrast to other dioxygenases or monooxyge-
nases studied to date, under physiological conditions, most of hIDO binds dioxy-
gen to form the oxy species first with a rate of 5.3*10(5) M-1s-1. It is followed by
rapid binding of the substrate, L-Trp, with a rate of ca. 9.0*10(6) M-1s-1, to form
the ternary complex, L-Trp-bound oxy species of hIDO.
Enzymes
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The initial and rate-limiting step of the kynurenine pathway involves the oxi-
dation of L-Trp to N-formyl kynurenine catalyzed by two hemeproteins, Try-
pophan 2,3 dioxygeanse (hTDO) and indoleamine 2,3-dioxygeanse (hIDO).
Although hTDO and hIDO catalyze the same reaction, and show high structural
homology, they are engaged in distinct physiological functions and show dif-
ferent biochemical properties. IDO has been implicated in diverse range of
pathophysiological conditions, whereas TDO deals with the systemic regula-
tion of the Trp flux in our body. Hence, understanding the differences between
hTDO and hIDO offer invaluable information for the design of new inhibitors
selective for hIDO. We have expressed, purified and characterized hTDO for
the first time and demonstrated that the distal pocket of the two heme enzymes
are distinctly different (JACS. 2007, 129, 15690-15701). In hTDO, the distal
H76 residue is believed to act as an active site base to deprotonate the indole
NH group of L-Trp, the initial step of the L-Trp oxidation reaction. In hIDO,
this histidine residue is replaced by a serine. To investigate the role of the H76
residue in hTDO, we have constructed two mutants, in which the H76 is replaced
by a serine or an alanine, and studied their structural and functional properties.
Resonance Raman studies indicate that L-Trp is positioned in the active site
by the ammonium, the carboxylate and the indole groups, via intricate H-bond-
ing and hydrophobic interactions. This scenario is consistent with the observa-
tion that L-Trp binding significantly perturbs the electronic properties of the
O2-complex of hTDO. The electronic properties of the active ternary complex
of hTDO are found to be sensitive to the mutation of the H76 residue, highlight-
ing the critical role of H76 in modulating the oxygen chemistry of hTDO.
2261-Pos Board B231
Insights Into The Mechanism Of The Cobalt Containing Nitrile Hydratase
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The crystal structures of the wild-type, Co(III) containing, nitrile hydratase and
the mutant (bF36L / bL103S / bY127N / aD4G) enzyme from have been solved
at resolutions of 1.4A and 1.15A respectively. Nitrile hydratases are noted for hav-
ing an unusual cysteine claw structure at the active site. An important observation
made in this paper is that cysteinesa119 and a121 were both modified to cysteine
sulfinic acid instead of the a121 cysteine sulfenic and a119 cysteine sulfinic acid
reported previously. This was confirmed by MALDI-TOF mass spectroscopy.
The nitrile hydratases catalyse the conversion of nitriles to the corresponding
amides. These enzymes underlie the industrial production ofacrylamide. In
the cysteine claw structure an Fe(III) or Co(III) ion is octahedrally co-ordinated
to three cysteines, two of which are oxidized, and two peptide backbone amide
groups. The sixth ligand, trans to the unmodified cysteine is a water molecule
or a hydroxide ion. The cysteine claw has the sequence CTLCSC in the iron
case and CSLCSC in the cobalt case. The enzyme itself is a a2b2 tetramer
with the cysteine claw located in the a subunit and much of the active site con-
tributed by the b subunit.
Our crystal structures are almost certainly an inactive form of the enzyme, be-
ing crystallized in 100 mM MES (2[N-Morpholino]ethanesulfonic acid) which
